[California] Carelon Medical Benefits Management updates
Effective date
Oct 1, 2026
Identified
Jun 25, 2026
Summary
Anthem Blue Cross (Medi-Cal Managed Care in California) is adopting updated Carelon Medical Benefits Management Clinical Appropriateness Guidelines effective October 1, 2026, covering six service categories: Genetic Testing, Chromosomal Microarray Analysis, Genetic Liquid Biopsy in Cancer Management, Pharmacogenetic Testing, Whole Exome/Genome Sequencing, and Musculoskeletal Interventional Pain Management. Existing prior authorization requirements remain unchanged, though new prior auth requirements may be announced separately before implementation.
Get alerts when payers change rules like this one
We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.
01Before October 1, 2026: Billing team and clinical staff should access and review the updated Carelon guidelines (via the provided link) for the six affected service categories to understand revised clinical appropriateness criteria.
02No billing code changes are required at this time, but staff should monitor for a separate notice regarding any new prior authorization implementations.
03Update internal reference materials and clinical decision support tools to reflect the new guidelines.
04Continue current prior auth processes until notified of changes.
Original notice
[California] Carelon Medical Benefits Management updates
providernews.anthem.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.